tetrahydrocurcumin has been researched along with Cancer of Colon in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, M; Choi, IW; Kim, DE; Oh, S; Park, BS; Ryu, MJ; Song, JY; Yun, YS | 1 |
| Badmaev, V; Ho, CT; Lai, CS; Nagabhushanam, K; Pan, MH; Wu, JC; Yu, SF | 1 |
2 other study(ies) available for tetrahydrocurcumin and Cancer of Colon
| Article | Year |
|---|---|
Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300.
Topics: Antineoplastic Agents; beta Catenin; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Curcumin; Diarylheptanoids; Down-Regulation; Humans; p300-CBP Transcription Factors; Wnt Proteins | 2008 |
Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta Catenin; Blotting, Western; Colon; Colonic Neoplasms; Curcumin; Down-Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred ICR; Phosphorylation; Wnt1 Protein | 2011 |